Does BLINATUMOMAB Cause Activated partial thromboplastin time prolonged? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Activated partial thromboplastin time prolonged have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.2% of all adverse event reports for BLINATUMOMAB.
21
Reports of Activated partial thromboplastin time prolonged with BLINATUMOMAB
0.2%
of all BLINATUMOMAB reports
5
Deaths
10
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From BLINATUMOMAB?
Of the 21 reports, 5 (23.8%) resulted in death, 10 (47.6%) required hospitalization, and 2 (9.5%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLINATUMOMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which BLINATUMOMAB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA